Search Results - "Li, Binkui"

Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply.

Authors: Liu, Wenwu Li, Binkui Yuan, Yunfei

Source: Alimentary Pharmacology & Therapeutics. Dec2018, Vol. 48 Issue 11/12, p1326-1327. 2p.

Author response to Letter to the Editor: 'Are inflammation‐based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?'.

Authors: Wang, Chenwei He, Wei Li, Binkui et al.

Source: Liver International. Jun2020, Vol. 40 Issue 6, p1499-1500. 2p. 1 Chart, 1 Graph.

Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria—Authors' reply.

Authors: Liu, Wenwu Li, Binkui Yuan, Yunfei

Source: Alimentary Pharmacology & Therapeutics. Nov2018, Vol. 48 Issue 9, p1027-1028. 2p. 1 Diagram.

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Authors: Wang, Chenwei Liao, Yadi He, Wei et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 3/18/2022, Vol. 41 Issue 1, p1-4. 4p.

Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma?

Authors: He, Wei Li, Binkui Yuan, Yunfei

Source: Alimentary Pharmacology & Therapeutics. Jan2023, Vol. 57 Issue 1, p173-174. 2p.

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

Authors: Yang, Zhiwen Yuan, Yichuan Niu, Yi et al.

Source: Cellular Oncology (2211-3428). Apr2025, Vol. 48 Issue 2, p505-522. 18p.

S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.

Authors: Zhong, Chengrui Niu, Yi Liu, Wenwu et al.

Source: Advanced Science; Oct2022, Vol. 9 Issue 30, p1-15, 15p

m⁶A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.

Authors: Lin, Zhu Huang, Zhenkun Qiu, Jiliang et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 7/25/2024, Vol. 43 Issue 1, p1-18. 18p.

Regorafenib with immunotherapy versus regorafenib alone as second‐line treatment for hepatocellular carcinoma: A multicenter real‐world study.

Authors: Qiao, Liang He, Wei Wang, Guoying et al.

Source: Cancer Medicine. May2024, Vol. 13 Issue 9, p1-13. 13p.

RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.

Authors: Qiu, Zhiyu Wang, Chenwei Huang, Pinzhu et al.

Source: Clinical & Translational Medicine. Dec2023, Vol. 13 Issue 12, p1-19. 19p.

This result is not displayed to guests.
Login for full access.

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma.

Authors: Lin, Zhu Huang, Zhenkun Shi, Yunxing et al.

Source: Cancer Cell International. 4/4/2023, Vol. 23 Issue 1, p1-13. 13p.

Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Authors: He, Wei Li, Binkui Zheng, Yun et al.

Source: Liver International. Nov2016, Vol. 36 Issue 11, p1677-1687. 11p. 4 Charts, 3 Graphs.

Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.

Authors: Zhang, Yuanping Wang, Yongjin Yuan, Yichuan et al.

Source: World Journal of Surgical Oncology. 5/18/2020, Vol. 18 Issue 1, p1-10. 10p.

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Authors: Wang, Chenwei Liao, Yadi He, Wei et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 3/26/2021, Vol. 40 Issue 1, p1-18. 18p.

Comparison of the prognostic value of inflammation‐based scores in early recurrent hepatocellular carcinoma after hepatectomy.

Authors: Wang, Chenwei He, Wei Yuan, Yichuan et al.

Source: Liver International. Jan2020, Vol. 40 Issue 1, p229-239. 11p. 5 Charts, 3 Graphs.

Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.

Authors: Yang, Zhiwen Zou, Ruhai Zheng, Yun et al.

Source: European Radiology. Nov2019, Vol. 29 Issue 11, p5752-5762. 11p. 1 Color Photograph, 1 Diagram, 4 Charts, 2 Graphs.

Subjects: Treatment effectiveness, Portal vein, Thrombosis, Progression-free survival, Antineoplastic agents, Cardiovascular surgery, Hepatocellular carcinoma, Liver tumors, Prognosis, Research funding, Vegetable oils, Retrospective studies, Disease progression, Chemoembolization

Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone.

Authors: Dai, Yunzhu Zhang, Yuanping He, Wei et al.

Source: International Journal of Hyperthermia. 2021, Vol. 38 Issue 1, p372-381. 10p.

Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.

Authors: Huang, Pinzhu Qiu, Jiliang You, Jinghong et al.

Source: Biomarkers. Aug2012, Vol. 17 Issue 5, p422-429. 8p. 3 Charts, 3 Graphs.

Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Authors: Liu, Wenwu Zheng, Yun He, Wei et al.

Source: Alimentary Pharmacology & Therapeutics. Sep2018, Vol. 48 Issue 6, p671-681. 11p. 3 Charts, 3 Graphs.